These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12415708)

  • 1. Vascular endothelial growth factor expression in non-small cell lung cancer.
    O'Byrne KJ; Goddard J; Giatromanolaki A; Koukourakis MI
    Methods Mol Med; 2003; 74():357-73. PubMed ID: 12415708
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic relevance of angiogenic, proliferative, and apoptotic factors in lung carcinomas. A case review.
    Volm M; Koomägi R
    Methods Mol Med; 2003; 74():269-82. PubMed ID: 12415702
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.
    Baillie R; Carlile J; Pendleton N; Schor AM
    J Clin Pathol; 2001 Feb; 54(2):116-20. PubMed ID: 11215279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
    Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
    Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
    Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients.
    Ferrari G; Scagliotti GV
    Eur J Cancer; 1996 Dec; 32A(13):2368-9. PubMed ID: 9038626
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer.
    Yano T; Tanikawa S; Fujie T; Masutani M; Horie T
    Eur J Cancer; 2000 Mar; 36(5):601-9. PubMed ID: 10738124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.
    Fontanini G; Faviana P; Lucchi M; Boldrini L; Mussi A; Camacci T; Mariani MA; Angeletti CA; Basolo F; Pingitore R
    Br J Cancer; 2002 Feb; 86(4):558-63. PubMed ID: 11870537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.
    Fujii T; Sudo T; Sueyoshi S; Tanaka T; Fujita H; Shirouzu K; Ban S; Toyonaga A; Kato S; Yamana H
    Int J Oncol; 2002 Dec; 21(6):1181-7. PubMed ID: 12429966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC).
    Oshika Y; Nakamura M; Tokunaga T; Ohnishi Y; Abe Y; Tsuchida T; Tomii Y; Kijima H; Yamazaki H; Ozeki Y; Tamaoki N; Ueyama Y
    Eur J Cancer; 2000 Dec; 36(18):2390-6. PubMed ID: 11094315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in epithelian ovarian cancer.
    Bamberger ES; Perrett CW
    Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
    Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
    Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
    Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
    J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Leigh IM; Georgoulias V; Kanavaros P; Sivridis E; Gatter KC; Harris AL
    Cancer Res; 1999 Nov; 59(21):5602-7. PubMed ID: 10554041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.